Centessa Pharmaceuticals
Stock Forecast, Prediction & Price Target
Centessa Pharmaceuticals (CNTA) stock Price Target by analysts
$23.25
Potential upside: 31.50%
Centessa Pharmaceuticals price prediction
What is Centessa Pharmaceuticals stock analysts` prediction?
Centessa Pharmaceuticals stock forecast: Based on 4 Wall Street analysts` predicted price targets for Centessa Pharmaceuticals in the last 3 months, the avarage price target is $23.25, with a high forecast of $NaN. The average price target represents a 31.50% change from the last price of $17.68.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Centessa Pharmaceuticals stock Price Target by analysts
Full breakdown of analysts given Centessa Pharmaceuticals price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Debjit Chattopadhyay Guggenheim | 0% 0/1 | 10 months ago | $28 58.37% upside | $17.1 | StreetInsider | Previous targets (0) |
Jeffrey Hung Morgan Stanley | 0% 0/1 | 12 months ago | $26 47.05% upside | $15.85 | TheFly | Previous targets (0) |
Kelly Shi Jefferies | 0% 0/1 | 12 months ago | $19 7.46% upside | $14.99 | StreetInsider | Previous targets (0) |
Kostas Biliouris BMO Capital | 0% 0/2 | 12 months ago | $20 13.12% upside | $16.02 | StreetInsider | Previous targets (1) |
Kostas Biliouris BMO Capital | 0% 0/2 | about 1 year ago | $15 -15.15% downside | $12.6 | StreetInsider | Previous targets (1) |
Centessa Pharmaceuticals Financial Estimates
Centessa Pharmaceuticals Revenue Estimates
Centessa Pharmaceuticals EBITDA Estimates
Centessa Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $6.85M 0% | Avg: $269.5K Low: $269.5K High: $269.5K avg. -96.06% | Avg: $36.37M Low: $36.37M High: $36.37M avg. 13397.85% | Avg: $131.9M Low: $131.9M High: $131.9M avg. 262.59% | Avg: $200.6M Low: $200.6M High: $200.6M avg. 52.08% |
Net Income
% change YoY
| $-381.85M N/A | $-216.20M 43.37% | $-151.08M 30.12% | Avg: $-201.73M Low: $-176.00M High: $-126.95M avg. -33.52% | Avg: $-197.93M Low: $-159.65M High: $-93.29M avg. 1.88% | Avg: $-89.92M Low: $-89.92M High: $-89.92M avg. 54.56% | Avg: $-52.41M Low: $-52.41M High: $-52.41M avg. 41.71% |
EBITDA
% change YoY
| $-139.28M N/A | $-207.94M -49.29% | $-166.06M 20.13% | Avg: $161.7K Low: $161.7K High: $161.7K avg. 100.09% | Avg: $21.82M Low: $21.82M High: $21.82M avg. 13397.85% | Avg: $79.14M Low: $79.14M High: $79.14M avg. 262.59% | Avg: $120.36M Low: $120.36M High: $120.36M avg. 52.08% |
EPS
% change YoY
| -$4.24 N/A | -$2.31 45.51% | -$1.57 32.03% | Avg: -$1.6 Low: -$1.83 High: -$1.32 avg. -1.59% | Avg: -$1.35 Low: -$1.66 High: -$0.97 avg. 15.67% | Avg: -$0.94 Low: -$0.94 High: -$0.94 avg. 30.48% | Avg: -$0.55 Low: -$0.55 High: -$0.55 avg. 41.71% |
Operating Expenses
% change YoY
| $139.28M N/A | $210.28M 50.97% | $178.13M -15.28% | Avg: $631.83K Low: $631.83K High: $631.83K avg. -99.64% | Avg: $85.28M Low: $85.28M High: $85.28M avg. 13397.86% | Avg: $309.23M Low: $309.23M High: $309.23M avg. 262.59% | Avg: $470.29M Low: $470.29M High: $470.29M avg. 52.08% |
FAQ
What is Centessa Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 16.15% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -176.00M, average is -201.73M and high is -126.95M.
What is Centessa Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 3404.11% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $269.5K, average is $269.5K and high is $269.5K.
What is Centessa Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 21.56% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$1.83, average is -$1.6 and high is $-1.32.
What is the best performing analyst?
In the last twelve months 4 analysts have been covering Centessa Pharmaceuticals stock. The most successful analyst is Debjit Chattopadhyay.